002281SZSE

"ACCELINK TECHNOLOGIES CO., LTD. 2025 Annual Stock Issuance Plan for Specific Objects (Draft)"

✨ AI Summary

This announcement outlines the plan for ACCELINK TECHNOLOGIES CO., LTD. to issue stocks to specific investors in 2025, subject to regulatory approvals. The total amount to be raised is expected to be no more than 350 million yuan, with a maximum of 242,055,525 shares to be issued. The funds will be allocated to various projects, including the development of optical communication products and research initiatives.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Statement

The company and all directors and senior management commit that this prospectus does not contain any false or misleading statements or major omissions, and guarantee the truthfulness, accuracy, and completeness of the disclosed information. The person in charge of the company, the person in charge of accounting work, and the head of the accounting institution (accounting supervisor) guarantee the authenticity and completeness of the financial accounting reports in this prospectus. The China Securities Regulatory Commission and the Shenzhen Stock Exchange do not guarantee the authenticity, accuracy, and completeness of the issuer's application documents and disclosed information, nor do they make substantive judgments or guarantees regarding the issuer's profitability, investment value, or returns to investors. Any contrary statements are false and misleading. According to the Securities Law, after the stocks are legally issued, the changes in the issuer's operations and earnings are the issuer's own responsibility. Investors should independently assess the issuer's investment value, make their own investment decisions, and bear the investment risks arising from changes in the issuer's operations and earnings or stock price after the legal issuance of stocks.

Major Matters Reminder

The issuer particularly reminds investors to pay attention to the following major matters or risk factors and to read the relevant sections of this prospectus carefully.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.